In more detail, TKRs are involved in different cell signalling pathways such as cellular proliferation, migration and survival, thus emerging as potential therapeutic targets in SCLC, and c-Kit is a member of the PDGF/c-Kit tyrosine kinase receptor family. This evidence concerns the gene NTRK1 and small cell lung carcinoma.